Safety and efficacy of doxorubicin-eluting superabsorbent polymer microspheres for the treatment of liver metastases from neuroendocrine tumours: preliminary results

by Bonne Lawrence, Verslype Chris, Laenen Annouschka, Cornelissen Sandra, Deroose Christophe M., Prenen Hans, Vandecaveye Vincent, Van Cutsem Eric, Maleux Geert
Published 2017-02-01

A phase I radiation dose-escalation study to determine the maximal dose of radiotherapy in combination with weekly gemcitabine in patients with locally advanced pancreatic adenocar...

by Aerts Raymond, Topal Baki, Van Steenbergen Werner, Van Cutsem Eric, Haustermans Karin, Budiharto Tom, Ectors Nadine, Bielen Didier, Vanbeckevoort Dirk, Goethals Laurence, Verslype Chris
Published 2008-09-01

Matrix-comparative genomic hybridization from multicenter formalin-fixed paraffin-embedded colorectal cancer tissue blocks

by Köhne Claus-Henning, Van Cutsem Eric, Belluco Claudio, Nordlinger Bernard, Radvanyi François, Julié Catherine, Aust Daniela E, Buchholz Malte, Sträter Jörn, Radlwimmer Bernhard, Fensterer Heiko, Kestler Hans A, Schwaenen Carsten, Nessling Michelle, Lutz Manfred P, Lichter Peter, Gress Thomas M
Published 2007-04-01

LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases--a randomized, placebo-controlled, multicenter, multinational, double-blinded pha...

by Schimanski Carl, Möhler Markus, Schön Michael, van Cutsem Eric, Greil Richard, Bechstein Wolf, Hegewisch-Becker Susanna, von Wichert Götz, Vöhringer Matthias, Heike Michael, Heinemann Volker, Peeters Marc, Kanzler Stephan, Kasper Stefan, Overkamp Friedrich, Schröder Jan, Seehofer Daniel, Kullmann Frank, Linz Bernhard, Schmidtmann Irene, Smith-Machnow Victoria, Gockel Ines, Lang Hauke, Galle Peter R
Published 2012-04-01

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and T...

by Muro, Kei, Lordick, Florian, Tsushima, Takahiro, Pentheroudakis, George, Baba, Eishi, Lu, Zhihao, Cho, Byoung Chul, Nor, I.M., Ng, Matthew, Chen, Li Tzong, Kato, Ken, Li, Jin, Ryu, Min-hee, Wan Zamaniah, Wan Ishak, Yong, Wei Peng, Yeh, Kun Huei, Nakajima, Takako Eguchi, Shitara, Kouhei, Kawakami, Hisato, Narita, Yukiya, Yoshino, Takayuki, Van Cutsem, Eric, Martinelli, Erika, Smyth, Elizabeth C., Arnold, Dirk, Minami, Hironobu, Tabernero, J., Douillard, Jean Yves
Published 2019

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS

by Muro, Kei, Van Cutsem, Eric, Narita, Yukiya, Pentheroudakis, George, Baba, Eishi, Li, Jin, Ryu, Min-hee, Wan Zamaniah, Wan Ishak, Yong, Wei Peng, Yeh, Kun Huei, Kato, Ken, Lu, Zhihao, Cho, Byoung Chul, Nor, I.M., Ng, Matthew, Chen, Li Tzong, Nakajima, Takako Eguchi, Shitara, Kouhei, Kawakami, Hisato, Tsushima, Takahiro, Yoshino, Takayuki, Lordick, Florian, Martinelli, Erika, Smyth, Elizabeth C., Arnold, Dirk, Minami, Hironobu, Tabernero, J., Douillard, Jean Yves
Published 2019

First-line pembrolizumab/placebo plus trastuzumab and chemotherapy in HER2-positive advanced gastric cancer: KEYNOTE-811

by Chung, Hyun Cheol, Bang, Yung-Jue, S Fuchs, Charles, Qin, Shu-Kui, Satoh, Taroh, Shitara, Kohei, Tabernero, Josep, van Cutsem, Eric, Alsina, Maria, Cao, Zhu Alexander, Lu, Jia, Bhagia, Pooja, Shih, Chie-Schin, Janjigian, Yelena Y.
Published 2022

KEYNOTE-859: a Phase III study of pembrolizumab plus chemotherapy in gastric/gastroesophageal junction adenocarcinoma

by Tabernero, Josep, Bang, Yung-Jue, Van Cutsem, Eric, Fuchs, Charles S., Janjigian, Yelena Yuriy, Bhagia, Pooja, Li, Kan, Adelberg, David, Qin, Shu Kui
Published 2022

KEYNOTE-585: Phase III study of perioperative chemotherapy with or without pembrolizumab for gastric cancer

by Bang, Yung-Jue, Van Cutsem, Eric, Fuchs, Charles S., Ohtsu, Atsushi, Tabernero, Josep, Ilson, David H., Hyung, Woo Jin, Strong, Vivian E., Goetze, Thorsten Oliver, Yoshikawa, Takaki, Tang, Laura H., Hwang, Peggy May Tan, Webb, Nancy, Adelberg, David, Shitara, Kohei
Published 2021

Progression-Free Survival as a Surrogate for Overall Survival in Advanced/Recurrent Gastric Cancer Trials: A Meta-Analysis

by Paoletti, Xavier, Oba, Koji, Bang, Yung-Jue, Bleiberg, Harry, Boku, Narikazu, Bouche, Olivier, Catalano, Paul, Fuse, Nozomu, Michiels, Stefan, Moehler, Markus, Morita, Satoshi, Ohashi, Yasuo, Ohtsu, Atsushi, Roth, Arnaud, Rougier, Philippe, Sakamoto, Junichi, Sargent, Daniel, Sasako, Mitsuru, Shitara, Kohei, Thuss-Patience, Peter, Van Cutsem, Eric, Burzykowski, Tomasz, Buyse, Marc
Published 2021

Quality of Life in the Trastuzumab for Gastric Cancer Trial

by Satoh, Taroh, Bang, Yung-Jue, Gotovkin, Evgeny A., Hamamoto, Yasuo, Kang, Yoon-Koo, Moiseyenko, Vladimir M., Ohtsu, Atsushi, Van Cutsem, Eric, Al-Sakaff, Nedal, Urspruch, Alexa, Hill, Julie, Weber, Harald A., Chung, Hyun-Cheol
Published 2021

Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer - Differential treatment strategies for...

by Lutz, Manfred P., Zalcberg, John R., Ducreux, Michel, Ajani, Jaffer A., Allum, William, Aust, Daniela, Bang, Yung-Jue, Cascinu, Stefano, Hoelscher, Arnulf, Jankowski, Janusz, Jansen, Edwin P. M., Kisslich, Ralf, Lordick, Florian, Mariette, Christophe, Moehler, Markus, Oyama, Tsuneo, Roth, Arnaud, Rueschoff, Josef, Ruhstaller, Thomas, Seruca, Raquel, Stahl, Michael, Sterzing, Florian, van Cutsem, Eric, van der Gaast, Ate, van Lanschot, Jan, Ychou, Marc, Otto, Florian
Published 2021

Role of chemotherapy for advanced/recurrent gastric cancer: An individual-patient-data meta-analysis

by The GASTRIC Group, Oba, Koji, Paoletti, Xavier, Bang, Yung-Jue, Bleiberg, Harry, Burzykowski, Tomasz, Fuse, Nozomu, Michiels, Stefan, Morita, Satoshi, Ohashi, Yasuo, Pignon, Jean-Pierre, Rougier, Philippe, Sakamoto, Junichi, Sargent, Daniel, Sasako, Mitsuru, Shitara, Kohei, Tsuburaya, Akira, Van Cutsem, Eric, Buyse, Marc
Published 2021

Everolimus for Previously Treated Advanced Gastric Cancer: Results of the Randomized, Double-Blind, Phase III GRANITE-1 Study

by Ohtsu, Atsushi, Ajani, Jaffer A., Bai, Yu-Xian, Bang, Yung-Jue, Chung, Hyun-Cheol, Pan, Hong-Ming, Sahmoud, Tarek, Shen, Lin, Yeh, Kun-Huei, Chin, Keisho, Muro, Kei, Kim, Yeul Hong, Ferry, David, Tebbutt, Niall C., Al-Batran, Salah-Eddin, Smith, Heind, Costantini, Chiara, Rizvi, Syed, Lebwohl, David, Van Cutsem, Eric
Published 2021

HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer

by Van Cutsem, Eric, Bang, Yung-Jue, Feng-Yi, Feng, Xu, Jian M., Lee, Keun-Wook, Jiao, Shun-Chang, Chong, Jorge Leon, Lopez-Sanchez, Roberto I., Price, Timothy, Gladkov, Oleg, Stoss, Oliver, Hill, Julie, Ng, Vivian, Lehle, Michaela, Thomas, Marlene, Kiermaier, Astrid, Rueschoff, Josef
Published 2021

Efficacy of pembrolizumab monotherapy for advanced gastric/gastroesophageal junction cancer with programmed death ligand 1 combined positive score ≥10

by Wainberg, Zev A., Fuchs, Charles S., Tabernero, Josep, Shitara, Kohei, Muro, Kei, Van Cutsem, Eric, Bang, Yung-Jue, Chung, Hyun Cheol, Yamaguchi, Kensei, Varga, Eniko, Chen, Jen-Shi, Hochhauser, Daniel, Thuss-Patience, Peter, Al-Batran, Salah-Eddin, Garrido, Marcelo, Kher, Uma, Shih, Chie-Schin, Shah, Sukrut, Bhagia, Pooja, Chao, Joseph
Published 2022

Health-related quality of life in advanced gastric/gastroesophageal junction cancer with second-line pembrolizumab in KEYNOTE-061

by Van Cutsem, Eric, Amonkar, Mayur, Fuchs, Charles S., Alsina, Maria, Ozguroglu, Mustafa, Bang, Yung-Jue, Chung, Hyun Cheol, Muro, Kei, Goekkurt, Eray, Benson, Al B., III, Sun, Weijing, Wainberg, Zev A., Norquist, Josephine M., Chen, Xinqun, Shih, Chie-Schin, Shitara, Kohei
Published 2022

Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors.

by Raymond, Eric, Dahan, Laetitia, Raoul, Jean-Luc, Bang, Yung-Jue, Borbath, Ivan, Lombard-Bohas, Catherine, Valle, Juan, Metrakos, Peter, Smith, Denis, Vinik, Aaron, Chen, Jen-Shi, Hoersch, Dieter, Hammel, Pascal, Wiedenmann, Bertram, Van Cutsem, Eric, Patyna, Shem, Lu, Dongrui Ray, Blanckmeister, Carolyn, Chao, Richard, Ruszniewski, Philippe
Published 2021

Effectiveness of Patient Adherence Groups as a Model of Care for Stable Patients on Antiretroviral Therapy in Khayelitsha, Cape Town, South Africa

by Luque-Fernandez, Miguel Angel, Van Cutsem, Gilles, Goemaere, Eric, Hilderbrand, Katherine, Schomaker, Michael, Mantangana, Nompumelelo, Mathee, Shaheed, Dubula, Vuyiseka, Ford, Nathan, Boulle, Andrew, Hernan, Miguel Angel
Published 2013

Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: KEYNOTE-164.

by Le, Dung T, Kim, Tae Won, Van Cutsem, Eric, Geva, Ravit, Jäger, Dirk, Hara, Hiroki, Burge, Matthew, O'Neil, Bert, Kavan, Petr, Yoshino, Takayuki, Guimbaud, Rosine, Taniguchi, Hiroya, Elez, Elena, Al-Batran, Salah-Eddin, Boland, Patrick M, Crocenzi, Todd, Atreya, Chloe E, Cui, Yi, Dai, Tong, Marinello, Patricia, Diaz, Luis A, André, Thierry
Published 2020